ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ Investing
This could be the biggest risk to ResMed's (ASX:RMD) share price run in FY19
⏸️ Investing
Top brokers name 3 ASX shares to sell
⏸️ Dividend Shares
Where I would reinvest my dividends
⏸️ Investing
Why I think RESMED (ASX:RMD) offers great value at this share price
⏸️ Investing
Why I would invest $5,000 in these top ASX shares
⏸️ Investing
UBS picks the best growth stocks to back for the new financial year
⏸️ Investing
Why the Australian dollar is near a 52-week low & could slide further in 2019
⏸️ Investing
3 stellar ASX shares for growth investors
⏸️ Investing
Why the ResMed Inc. (ASX:RMD) share price just hit another record high
⏸️ Investing
UBS just added these 2 blue-chip shares to its model portfolio
⏸️ Investing
3 healthcare shares I want in my portfolio
⏸️ Investing
Why I think these healthcare shares are top buy and hold options
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
